Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
U.S. Sees Increase in Infant Botulism Cases
(MENAFN) A total of 31 cases of infant botulism have been confirmed across 15 U.S. states as of Wednesday, the U.S. Food and Drug Administration (FDA) reported, as investigators probe a potential connection to contaminated infant formula.
According to the FDA, “Epidemiologic and laboratory data show that ByHeart Whole Nutrition infant formula might be contaminated with Clostridium botulinum, which is causing infant illness in multiple regions of the country.”
All affected infants have required hospitalization, though no deaths have been reported. Of those with demographic information available, ages range from 16 to 200 days, and 11 are female.
The FDA warned that recalled formula continues to appear on store shelves in several states. “We are working with state partners and retailers to ensure the recall is effectively implemented,” the agency said.
The agency also highlighted that the recalled formula had been sold through online marketplaces and shipped to customers internationally, and it warned consumers around the world to avoid using any ByHeart brand infant formula.
The FDA confirmed that its investigation to determine the source of contamination is ongoing.
MENAFN20112025000045017169ID1110372653